Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-21-021581
Filing Date
2021-07-06
Accepted
2021-07-06 16:31:10
Documents
2
Period of Report
2021-07-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1396
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 3967
  Complete submission text file 0001127602-21-021581.txt   6779
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Issuer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Burton Paul (Reporting) CIK: 0001869869 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38753 | Film No.: 211074504